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In previous studies we demonstrated that individuals infected by human T-cell leukemia virus type II (HTLV-II) presented
a high degree of variation in proviral load and that the cellular tropism of this virus was expanded in some patients to
B-lymphocytes. To understand whether the observed high proviral load could be associated with the clonal expansion of
the infected cells, we have studied the mode of integration of HTLV-II in six infected individuals with proviral load higher
than 1% of total peripheral blood mononuclear cells (PBMCs). An inverse polymerase chain reaction (PCR) analysis, which
allowed the amplification of the region flanking the 5* end of the provirus, was developed for HTLV-II. A single band,
corresponding to a monoclonal expansion, was found in four of six patients analyzed, while in the other two patients an
oligoclonal type of integration was observed. The results for inverse PCR analysis were confirmed by sequencing the PCR
products and showing that the 5* LTR flanking sequences of proviral DNA obtained from the different subjects presented
no homology, thus suggesting that no specific site or sequence is required for the integration process of HTLV-II. The
results indicate that the HTLV-II high proviral load observed in PBMCs from infected patients is associated with a clonal
expansion of HTLV-II-infected cells. This study also suggests that the very high genetic stability of HTLV-II could be explained
by viral amplification via clonal expansion rather than by reverse transcription. q 1996 Academic Press, Inc.
The human T-cell leukemia virus type II (HTLV-II), al- provirus. The assay was performed on DNA samples
obtained from the PBMCs of six individuals with a provi-though initially isolated from a patient with an atypical
T-cell malignancy (1), has not yet been firmly associated ral copy number higher than 1% of total PBMCs (9). The
study population included one Italian IDU (Pe), two sub-to any human disease. However, there is growing evi-
dence that HTLV-II is involved with neurodegenerative jects from the Bahoumbou ethnic group of Gabon (Ph226
and Ph227) (11), one from a Pygmy group of Cameroonand lymphoproliferative disorders (2–4). HTLV-II infec-
(Pyg220) (12), and two subjects from Argentina, one oftion was demonstrated in a significant proportion of in-
which was from the Tobas (For2) and the other from thejecting drug users (IDUs) in the United States and in
Pilaga (Pil) ethnic groups. The HTLV-II genomic structureEurope (5 – 7) and was shown to be endemic among sev-
of all six subjects belonged to the IIb subtype.eral American Indian tribes (8).
The scheme for the inverse PCR procedure is depictedBy using a new competitive PCR system for the quanti-
in Fig. 1A. When an inverse PCR is carried out on proviralfication of HTLV-II proviral copies in peripheral blood
DNA, amplification products corresponding to 5* LTR andlymphocytes (PBMCs) of infected patients, we recently
3* LTR regions are obtained. In our HTLV-II proviral sys-reported that a great variation in HTLV-II proviral load
tem, the 5* LTR inverse PCR products are linked to geno-among infected individuals from different geographic ori-
mic DNA, whereas the 3* LTR products always presentgin was occurring (9) and that cellular tropism of HTLV-
a single band of 541 nt containing a fragment of the taxII was enlarged to B-lymphocytes in patients with high
gene.proviral load (10). To verify whether the high proviral load
The inverse PCR technique has already been used toobserved in some patients could be associated with the
identify clonal forms of retroviral integration, includingclonal expansion of HTLV-II-infected cells, we have de-
HIV-1 (13) and HTLV-I (14). We have validated our inverseveloped an inverse PCR procedure which allowed the
PCR assay for HTLV-II by determining its sensitivity andamplification of the region flanking the 5* end of the
its capacity in distinguishing the various clonal inser-
tions. To address these questions, inverse PCR reactions1 To whom reprint requests should be addressed at the Istituto di
were constructed with limiting dilutions of LTR-bearingBiologia e Genetica, Universita` di Verona, Strada le Grazie, 8, I-37134
Verona, Italy. Fax: /39-45-8098188. plasmids presenting different sizes and LTR flanking se-
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quences. In the first experiment, shown in Fig. 2A, three
different plasmids (H61, TA, and PBS) were mixed to-
gether at the concentration of 50 copies each in a back-
ground of genomic DNA from uninfected subjects. Four
distinct bands were visible since plasmid H61, which
bears the entire HTLV-II provirus (15), yielded two amplifi-
cation products of 541 and 440 bp, respectively. These
results demonstrate that the PCR signal is still visible at
FIG. 2. (A) Southern blot of inverse PCR amplification products ob-very low concentration so that poorly represented clonal
tained from plasmid DNA bearing LTR insertion sequences, at limiting
insertions can also be detected after the inverse PCR concentrations (see text). Plasmid H61 yielded two bands of 541 and
reaction. To possibly understand whether one insertion 440 bp, plasmid TA one band of 292 bp, and plasmid PBS one band
site could dominate the PCR reaction, a second assay of 225 bp. (B) Inverse PCR analysis of plasmid TA (292 bp) and PBS
(225 bp) at the concentration of 100 copies each in the amplificationwas performed in which two LTR plasmids with different
reaction.flanking sequences were diluted with genomic DNA from
uninfected subjects and mixed at the same concentration
(100 copies each). The results, reported in Fig. 2B, show
the presence of two distinct bands, as expected, though
the intensity of the signal is higher for the 225-bp band.
It is evident that the efficiency of amplification can differ
for each insertion site but all existing clones can be
amplified and are detected on the Southern blot within
the sensitivity limit of the method. When the inverse PCR
analysis was performed on proviral DNA obtained from
stabilized Bjab cells infected by HTLV-II GU (16), no dis-
crete bands were visible on the gel (not shown), as ex-
pected in the case of in vitro infection, where polyclonal
integration is the norm.
By using the inverse PCR procedure, the genomic DNA
obtained from the six subjects with high HTLV-II proviral
load was analyzed. The results obtained for the IDU pa-
tient Pe are shown in Fig. 1B. Only two bands were
visualized on Southern blot: one of 541 bp corresponding
to the expected inverse PCR product of 3* LTR tax and
a second of 350 bp corresponding to the 5* LTR fragment
containing the genomic flanking region. The presence of
a single 5* LTR band clearly indicates that the same
genomic sequence was flanking the 5* end of the provi-
rus, thus suggesting that a monoclonal type of integration
had occurred. Similar results were obtained for DNA
samples purified from PBMCs of subjects Ph226, For2,
and Pyg220, where single 5* LTR products of 237, 215,
and 203 bp, respectively, were observed on Southern
blots. In the two remaining cases, several 5* LTR bandsFIG. 1. (A) Scheme for the inverse PCR procedure for HTLV-II proviral
were found after Southern blotting: two amplified prod-DNA. Genomic DNA purified from PBMCs of infected individuals was
digested for 24 hr with MspI, which cuts the 5* LTR region at position ucts of 210 and 361 bp for sample Pil (see Fig. 1C) and
334 of HTLV-IIb isolates. A 300-ng aliquot of digested DNA was treated four bands of 170, 220, 240, and 355 bp for sample Ph227.
with 100 U of T4 DNA ligase in conditions favoring the formation of It is evident that in the last two cases an oligoclonal type
monomeric circles (14). The products of the ligation reaction were
of integration had occurred.amplified back to back by means of inverse PCR by using primers A
It has been recently reported by Chou et al. (17) that,(nt 48–68) and Arr (nt 275–293), which are designed to obtain the
amplification of the genome region flanking the 5* LTR. The reaction in patients with adult T-cell leukemia and infected by
was carried out in a final volume of 100 ml with 20 pmol primers, 2 HTLV-I, the region flanking the provirus presented pre-
mM MgCl2 , 2.5 U Taq polymerase (Perkin–Elmer Cetus) for 50 cycles ferred nucleotide sequences with an enrichment in A–T
(1 min at 927, 1 min at 557, 2 min at 727). One-third of the PCR reaction
composition. In order to clarify this point also for HTLV-was analyzed on Southern blot by hybridization with a 32P-labeled probe
II and understand whether each 5* LTR product corre-(nt 26–46). (B) Inverse PCR analysis on genomic DNA from patient Pe.
(C) Inverse PCR analysis on genomic DNA from patient Pil. sponded to a specific restriction fragment and whether
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the integration site could present some homology in the with high proviral load could be more prone to develop
such diseases.different subjects, we have cloned (TA cloning kit; In-
vitrogen) and sequenced the inverse PCR products of
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